David A. Siegel Treace Medical Concepts, Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q3 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 33,000 shares of TMCI stock, worth $230,010. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,000
Previous 73,100
54.86%
Holding current value
$230,010
Previous $486,000
60.7%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding TMCI
# of Institutions
138Shares Held
39.7MCall Options Held
352KPut Options Held
269K-
Armistice Capital, LLC New York, NY6.2MShares$43.2 Million0.6% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$28.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.27MShares$22.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.74MShares$19.1 Million0.0% of portfolio
-
William Blair Investment Management, LLC Chicago, IL2.39MShares$16.7 Million0.04% of portfolio
About TREACE MEDICAL CONCEPTS, INC.
- Ticker TMCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 55,403,300
- Market Cap $386M
- Description
- Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...